BUPRENORFIN ALKALOID

Sublingual tablet, 0.4mg
RxActive license

Active substance (INN)

buprenorphine

Pharmaceutical form

Pharmaceutical formSublingual tablet
Strength0.4mg
PackagingUkupno 7 sublingvalnih tableta u blisteru (1x7) u kartonskoj kutiji
ManufacturerAlkaloid AD Skopje, North Macedonia
Therapeutic groupNervous system (N07BC01)
Marketing authorization holderDRUŠTVO "ALKALOID" D.O.O. PODGORICA
Authorization dateAugust 24, 2023

Analogs in Montenegro

8

Other medicines with the same active substance

Source: CInMED register